Filtered Search Results
R&D Systems™ Recombinant Human EGF Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. (Observed): 6 kDa, reducing conditions; M.W. (theoretical): 6 kDa |
| Gene Symbol | EGF |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | EGF |
| Source | E. coli-derived human EGF protein Asn971-Arg1023, with an N-terminal Met |
| Name | EGF |
| Accession Number | P01133 |
| Gene ID (Entrez) | 1950 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 500 μg/mL in sterile PBS. |
| Recombinant | Recombinant |
R&D Systems™ Recombinant Human Lymphotoxin alpha1/beta2 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. (Observed): 13 kDa, under reducing conditions., M.W. (Theoretical): 15.1 kDa |
| Endotoxin Concentration | <0.10 EU per 1μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | IL-4 |
| Source | E. coli-derived human IL-4 protein His25-Ser153, with an N-terminal Met |
| Accession Number | P05112.1 |
| Gene Alias | B cell growth factor 1, BCDF, B-cell stimulatory factor 1, BCGF1, BCGF-1, binetrakin, BSF1, BSF-1, IL4, IL-4B_cell stimulatory factor 1, IL4E12, interleukin 4, interleukin-4, Lymphocyte stimulatory factor 1, MGC79402, Pitrakinra |
| Gene ID (Entrez) | 3565 |
| Formulation | Lyophilized from a 0.2μm filtered solution in PBS with Trehalose. |
| Reconstitution | Reconstitute the 10μg size at 100μg/mL in PBS. Reconstitute all other sizes at 500μg/mL in PBS. |
| Species | Human |
R&D Systems™ Recombinant Porcine PD-L1/B7-H1 Fc Chimera Protein
Measured by its binding ability in a functional ELISA.
R&D Systems™ Recombinant Human IL-13 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Conjugate | Unconjugated |
|---|---|
| Molecular Weight (g/mol) | 12.3 kDa |
| Gene ID (Entrez) | 3596 |
R&D Systems™ Recombinant Human IL-17A (Human Cell-expressed) Protein
Earn double rewards for reviews
| Buffer | Lyophilized from a 0.2 μm filtered solution in PBS. |
|---|---|
| Purity or Quality Grade | >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 15.1 kDa (monomer) |
| Endotoxin Level | <0.01 EU per 1 μg of the protein by the LAL method. |
| Gene Symbol | IL17A |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Source | Human embryonic kidney cell, HEK293-derived human IL-17/IL-17A protein Gly24-Ala155 |
| Name | CTLA8, CTLA-8, CTLA8cytotoxic T-lymphocyte-associated serine esterase 8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL17A, IL-17A, IL-17Acytotoxic T-lymphocyte-associated protein 8, IL-17CTLA-8, IL17interleukin-17A, interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8), interleukin 17A |
| Accession Number | Q16552 |
| Gene ID (Entrez) | 3605 |
| Reconstitution | Reconstitute at 100 μg/mL in PBS. |
| Species | Human |
R&D Systems™ Recombinant Human TNF-alpha (HEK293-expressed) Protein
Measured in a cytotoxicity assay using L-929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. ED50 for this effect is 20 to 100 pg/mL.
| Buffer | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
|---|---|
| Accession Number | P01375 |
| Purity or Quality Grade | >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 17 kDa |
| Gene ID (Entrez) | 7124 |
| Endotoxin Level | <0.10 EU per 1 μg of the protein by the LAL method. |
| Reconstitution | Reconstitute at 500 μg/mL in PBS. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Species | Human |
| Source | Human embryonic kidney cell, HEK293-derived human TNF-alpha protein Val77-Leu233 |
| Name | APC1 protein, Cachectin, Cachetin, DIF, TNF, TNF, monocyte-derived, TNF-a, TNFA, TNFalpha, TNF-alphacachectin, TNFATNF, macrophage-derived, TNFG1F, TNFSF1A, TNFSF2, TNFSF2TNF superfamily, member 2, tumor necrosis factor, tumor necrosis factor (TNF superfamily, member 2), tumor necrosis factor alpha, Tumor necrosis factor ligand superfamily member 2, tumor necrosis factor-alpha |
R&D Systems™ Recombinant Human TGF-beta 1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Conjugate | Unconjugated |
|---|---|
| Gene Alias | CEDLAP, DPD1, latency-associated peptide, TGF beta1, TGFB, TGFB1, TGFbeta, TGFbeta 1, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1 |
| Gene ID (Entrez) | 7040 |
| Structural Form | Disulfide-linked homodimer |
| Recombinant | Recombinant |
| Name | TGF-beta 1 |
R&D Systems™ Recombinant Human IL-2 Protein
Contains the Cysteine to Serine substitution found in Proleukin™ (aldesleukin)
| Accession Number | P60568.1 |
|---|---|
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Conjugate | Unconjugated |
| Gene Alias | aldesleukin, IL2, IL-2, IL-2 lymphokine, interleukin 2, interleukin-2, involved in regulation of T-cell clonal expansion, Proleukin, T cell growth factor, T-cell growth factor, TCGF |
| Molecular Weight (g/mol) | M.W.-observed: 13 kDa, under reducing conditions., M.W.-theroretical: 15.5 kDa |
| Gene ID (Entrez) | 3558 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in Sodium Acetate with Trehalose. |
| Reconstitution | Reconstitute the 10 μg size at 100 μg/mL in sterile deionized water. Reconstitute all other sizes (at 500 μg/mL in sterile deionized water.) |
| Endotoxin Concentration | <0.01 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | IL-2 |
| Source | E. coli-derived human IL-2 protein Ala21-Thr153 (Cys145Ser), with and without an N-terminal Met |
R&D Systems™ Recombinant Human IL-4 Protein, Animal-Free
Intended for preclinical researchers who may transition to GMP IL-4 for their clinical work
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. (Observed): 13 kDa, under reducing conditions., M.W. (Theoretical): 15.1 kDa |
| Endotoxin Concentration | <0.10 EU per 1μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | IL-4 |
| Source | E. coli-derived human IL-4 protein His25-Ser153, with an N-terminal Met Produced using non-animal reagents in an animal-free laboratory. |
| Accession Number | P05112.1 |
| Gene Alias | B cell growth factor 1, BCDF, B-cell stimulatory factor 1, BCGF1, BCGF-1, binetrakin, BSF1, BSF-1, IL4, IL-4B_cell stimulatory factor 1, IL4E12, interleukin 4, interleukin-4, Lymphocyte stimulatory factor 1, MGC79402, Pitrakinra |
| Gene ID (Entrez) | 3565 |
| Formulation | Lyophilized from a 0.2μm filtered solution in PBS with Trehalose. |
| Reconstitution | Reconstitute at 500μg/mL in PBS. |
| Species | Human |
R&D Systems™ Recombinant Human M-CSF Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 18.5 kDa (monomer) |
| Gene Symbol | CSF1 |
| Endotoxin Concentration | <1.0 EU per 1 μg of the protein by the LAL method. |
| For Use With (Application) | Bioactivity |
| Source | <EM>E. coli</EM>-derived human M-CSF protein Glu33-Ser190, with an N-terminal Met |
| Accession Number | NP_757350 |
| Regulatory Status | RUO |
| Gene ID (Entrez) | 1435 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
| Reconstitution | Reconstitute at 50-500 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
| Cross Reactivity | M-CSF |
| Species | Human |
R&D Systems™ Recombinant Human BDNF Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Buffer | Lyophilized from a 0.2 μm filtered solution in Sodium Citrate and NaCl with BSA as a carrier protein. |
|---|---|
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining. |
| Conjugate | Unconjugated |
| Specific Reactivity | BDNF |
| Molecular Weight (g/mol) | 13-14 kDa, under reducing conditions. |
| Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Source | Spodoptera frugiperda,Sf 21 (baculovirus)-derived BDNF protein His129-Arg247 Accession &Num; P23560 100% sequence homology with Mouse,Rat,Canine,Equine and all other mammalian proteins examined. |
| Accession Number | P23560 |
| Regulatory Status | RUO |
| Gene ID (Entrez) | 627 |
| Reconstitution | Reconstitute 5 μg vials at 100 μg/mL in water. Reconstitute 10 μg or larger vials at 250 μg/mL in water. |
| Species | Human,Mouse,Rat,Canine,Equine |
| Recombinant | Recombinant |
R&D Systems™ Human Thrombospondin-1 Quantikine ELISA Kit
Human Thrombospondin-1 Quantikine ELISA Kit from the most referenced ELISA manufacturer. Highly validated for accurate quantitation and long-term reproducibility.
R&D Systems™ Recombinant Human IL-6 Protein
A New rh IL-6 is Available! The new protein has ∼2 fold better activity and is HEK293 expressed!
| Purity or Quality Grade | >97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. theroretical: 20.9 kDa |
| Gene Symbol | IL6 |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | IL-6 |
| Source | E. coli-derived human IL-6 protein Pro29-Met212 |
| Name | IL-6 |
| Accession Number | Q75MH2 |
| Gene Alias | B-cell differentiation factor, B-cell stimulatory factor 2, BSF2, BSF-2, CDF, CTL differentiation factor, HSF, hybridoma growth factor, IFNB2, IFN-beta-2, IL6, IL-6, Interferon beta-2, interleukin 6 (interferon, beta 2), interleukin BSF-2, interleukin-6, MGI-2A |
| Gene ID (Entrez) | 3569 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS and NaCl. |
| Recombinant | Recombinant |